Skip to main content
SpringerLink
Log in

Los Alamos Hepatitis C Immunology Database

  • Database Report
  • Published:
Applied Bioinformatics

Abstract

The Los Alamos Hepatitis C Virus (HCV) Sequence Database (http://hcv.lanl.gov or http://hcv-db.org) was officially launched in September 2003. The sister HCV Immunology Database was made public in September 2004. The HCV Immunology Database is based on the Human Immunodeficiency Virus (HIV) Immunology Database. The HCV Immunology Database contains a curated inventory of immunological epitopes in HCV and their interaction with the immune system, with associated retrieval and analysis tools. This article describes in detail the types of data and services that the new database offers, the tools provided and the database framework. The data and some of the HCV database tools are available for download for non-commercial use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II
Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. World Health Organization. Hepatitis C. Fact sheet no. 164 [online]. October 2000. Available from URL: http://www.who.int/mediacentre/factsheets/fsl64/en/print.html [Accessed 2005 Nov 3]

  2. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899–905

    Article  PubMed  CAS  Google Scholar 

  3. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26: 15S–20S

    Article  PubMed  CAS  Google Scholar 

  4. Krahn M, Wong JB, Heathcote J, et al. Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990. Med Decis Making 2004; 24: 20–9

    Article  PubMed  Google Scholar 

  5. Grakoui A, Hanson HL, Rice CM. Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis. Hepatology 2001; 33: 489–95

    Article  PubMed  CAS  Google Scholar 

  6. Lanford RE, Bigger C. Advances in model systems for hepatitis C virus research. Virology 2002; 293: 1–9

    Article  PubMed  CAS  Google Scholar 

  7. Pawlotsky JM. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 2003; 59: 1–11

    Article  PubMed  CAS  Google Scholar 

  8. Fleckenstein J. Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep 2004; 6: 66–70

    Article  PubMed  Google Scholar 

  9. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–62

    Article  PubMed  CAS  Google Scholar 

  10. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–500

    Article  PubMed  CAS  Google Scholar 

  11. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 1994; 91: 7792–6

    Article  PubMed  CAS  Google Scholar 

  12. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995; 208: 653–61

    Article  PubMed  CAS  Google Scholar 

  13. Ishii K, Rosa D, Watanabe Y, et al. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology 1998; 28: 1117–20

    Article  PubMed  CAS  Google Scholar 

  14. Pavio N, Lai MM. The hepatitis C virus persistence: how to evade the immune system? J Biosci 2003; 28: 287–304

    Article  PubMed  CAS  Google Scholar 

  15. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999; 30: 595–601

    Article  PubMed  CAS  Google Scholar 

  16. Cooper S, Erickson AL, Adams EJ, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10: 439–49

    Article  PubMed  CAS  Google Scholar 

  17. Cucchiarini M, Kammer AR, Grabscheid B, et al. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol 2000; 203: 111–23

    Article  PubMed  CAS  Google Scholar 

  18. Darling JM, Wright TL. Immune responses in hepatitis C: is virus or host the problem? Curr Opin Infect Dis 2004; 17: 193–8

    Article  PubMed  CAS  Google Scholar 

  19. Erickson AL, Kimura Y, Igarashi S, et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001; 15: 883–95

    Article  PubMed  CAS  Google Scholar 

  20. Gruner NH, Gerlach TJ, Jung MC, et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000; 181: 1528–36

    Article  PubMed  CAS  Google Scholar 

  21. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191: 1499–512

    Article  PubMed  CAS  Google Scholar 

  22. Ward S, Lauer G, Isba R, et al. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol 2002; 128: 195–203

    Article  PubMed  CAS  Google Scholar 

  23. Gerlach JT, Diepolder HM, Jung MC, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999; 117: 933–41

    Article  PubMed  CAS  Google Scholar 

  24. Farci P, Purcell RH. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 2000; 20: 103–26

    PubMed  CAS  Google Scholar 

  25. Gaschen B, Taylor J, Yusim K, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002; 296: 2354–60

    Article  PubMed  CAS  Google Scholar 

  26. Kuiken C, Yusim K, Boykin L, et al. The Los Alamos hepatitis C sequence database. Bioinformatics 2005 Feb 1; 21(3): 379–84

    Article  PubMed  CAS  Google Scholar 

  27. Korber B, Brander C, Haynes B, et al. HIV molecular immunology 2002. Los Alamos (NM): Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 2003

    Google Scholar 

  28. Rolsky D, Williams K. Embedding Perl in HTML with Mason. Sebastopol (CA): O’Reilly & Associates Inc., 2003

    Google Scholar 

  29. Wall L, Christiansen T, Orwant J. Programming Perl. Sebastopol (CA): O’Reilly & Associates Inc., 2000

    Google Scholar 

  30. Stajich JE, Block D, Boulez K, et al. The Bioperl toolkit: Perl modules for the life sciences. Genome Res 2002; 12: 1611–8

    Article  PubMed  CAS  Google Scholar 

  31. Yusim K, Kesmir C, Gaschen B, et al. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002; 76: 8757–68

    Article  PubMed  CAS  Google Scholar 

  32. Los Alamos National Laboratory. Hepatitis C Virus (HCV) Immunology Database [online]. Available from URL: http://hcv.lanl.gov or http://hcv-db.org [Accessed 2005 Nov 3]

  33. Calef C, Thakalapally R, Lang D, et al. PeptGen: designing peptides for immunological studies and application to HIV consensus sequences. In: Korber BT, Brander C, Haynes B, et al., editors. HIV molecular immunology 2000. Los Alamos (NM): Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 2000: 163–7

    Google Scholar 

  34. Thakalapally R, Kibbe W, Lang D, et al. MotifScan: a web-based tool to find HLA anchor residues in proteins or peptides. In: Korber B, Brander C, Haynes B, et al., editors. HIV molecular immunology database 2000. Los Alamos (NM): Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 2000: 1–101–102. Report no.: LA-UR 02-2877

    Google Scholar 

  35. Yusim K, Szinger J, Honeyborne I, et al. Enhanced MotifScan: a tool to scan for HLA anchor residues in proteins, HIV molecular immunology 2003. Los Alamos (NM): Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 2004: 25–36

    Google Scholar 

  36. Calef C, Thakalapally R, Kaslow R, et al. ELF: an analysis tool for HIV-1 peptides and HLA types. In: Korber B, Brander C, Haynes B, et al., editors. HIV molecular immunology 2001. Los Alamos (NM): Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 2001:I–21–25. Report no.: LA-UR 02-2877

    Google Scholar 

  37. Sarobe P, Jauregui JI, Lasarte JJ, et al. Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment. J Hepatol 1996; 25: 1–9

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was performed under the Intragency agreement YI-AY-1500 (Hepatitis C Databases, LAUR: 04-7030) between US Department of Energy (DOE) and National Institute of Allergy and Infectious Diseases (NIAID).

The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

  1. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, USA

    Karina Yusim, Russell Richardson, Ning Tao, Anita Dalwani, Ashish Agrawal, James Szinger, Robert Funkhouser, Bette Korber & Carla Kuiken

Authors
  1. Karina Yusim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Russell Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ning Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anita Dalwani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ashish Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. James Szinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert Funkhouser
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bette Korber
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Carla Kuiken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karina Yusim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yusim, K., Richardson, R., Tao, N. et al. Los Alamos Hepatitis C Immunology Database. Appl-Bioinformatics 4, 217–225 (2005). https://doi.org/10.2165/00822942-200504040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00822942-200504040-00002

Keywords

Search

Navigation